The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 2933583)

Published in BMC Neurol on August 23, 2010

Authors

Nobue Shishioh-Ikejima1, Tokiko Ogawa, Kouzi Yamaguti, Yasuyoshi Watanabe, Hirohiko Kuratsune, Hiroshi Kiyama

Author Affiliations

1: Department of Anatomy & Neurobiology, Osaka City University, Graduate School of Medicine, Osaka 545-8585, Japan.

Articles cited by this

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med (1994) 26.24

Retracted Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science (2009) 10.76

Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One (2010) 4.66

Neuroendocrine aspects of the response to stress. Metabolism (2002) 1.71

Plasma cytokines in women with chronic fatigue syndrome. J Transl Med (2009) 1.55

Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Crit Care Med (2000) 1.53

The neuroendocrinology of chronic fatigue syndrome. Endocr Rev (2003) 1.52

Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today (1997) 1.37

Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun (2003) 1.10

alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J Biol Chem (2003) 1.09

Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. Neuroimage (2002) 1.05

Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf) (2004) 1.02

Establishment and assessment of a rat model of fatigue. Neurosci Lett (2003) 1.00

Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J Immunol (1988) 0.99

Symptom occurrence in persons with chronic fatigue syndrome. Biol Psychol (2002) 0.92

Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists--preliminary results. Scand J Rheumatol Suppl (2000) 0.90

Altered expression of neprilysin family members in the pituitary gland of sleep-disturbed rats, an animal model of severe fatigue. J Neurochem (2005) 0.84

Chronic stress elicits prolonged activation of alpha-MSH secretion and subsequent degeneration of melanotroph. J Neurochem (2009) 0.84

Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med (1998) 0.83

Increased prolactin response to buspirone in chronic fatigue syndrome. J Affect Disord (1996) 0.81

Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure. Intern Med (2006) 0.80

Plasma alpha-melanocyte-stimulating hormone: sex differences and correlations with obesity. Metabolism (2009) 0.79

Elevated plasma levels of alpha-melanocyte stimulating hormone (alpha-MSH) are correlated with insulin resistance in obese men. Int J Obes Relat Metab Disord (2000) 0.79

Plasma levels of alpha-melanotropin and ACTH-like immunoreactivities do not vary by season or skin type in women from southern and central Europe. Neuropeptides (2004) 0.78

Elevated concentrations of plasma alpha-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients. J Lab Clin Med (1999) 0.78

Articles by these authors

Directed differentiation of telencephalic precursors from embryonic stem cells. Nat Neurosci (2005) 4.34

mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol (2004) 3.72

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Ann Neurol (2008) 2.32

Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet (2003) 2.24

Expression of the activating transcription factor 3 prevents c-Jun N-terminal kinase-induced neuronal death by promoting heat shock protein 27 expression and Akt activation. J Neurosci (2003) 1.85

18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med (2006) 1.62

Effects of (-) -epigallocatechin gallate in liver of an animal model of combined (physical and mental) fatigue. Nutrition (2008) 1.58

64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer. J Nucl Med (2013) 1.46

High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol (2009) 1.45

Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol (2004) 1.45

Novel molecular imaging of atherosclerosis with gallium-68-labeled apolipoprotein A-I mimetic peptide and positron emission tomography. Circ J (2013) 1.43

Multi-directional differentiation of doublecortin- and NG2-immunopositive progenitor cells in the adult rat neocortex in vivo. Eur J Neurosci (2007) 1.42

Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography. J Control Release (2010) 1.41

Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus. Br J Haematol (2002) 1.40

Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann N Y Acad Sci (2002) 1.36

Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Invest (2004) 1.23

No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Retrovirology (2011) 1.22

Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition (2008) 1.21

Critical role for DP5/Harakiri, a Bcl-2 homology domain 3-only Bcl-2 family member, in axotomy-induced neuronal cell death. J Neurosci (2004) 1.18

Mental and physical fatigue-related biochemical alterations. Nutrition (2008) 1.14

Role of heme oxygenase-1 protein in the neuroprotective effects of cyclopentenone prostaglandin derivatives under oxidative stress. Eur J Neurosci (2003) 1.12

Relationships between dietary habits and the prevalence of fatigue in medical students. Nutrition (2008) 1.12

The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Haematologica (2006) 1.11

Attenuated fever in pregnant rats is associated with blunted syntheses of brain cyclooxygenase-2 and PGE2. Am J Physiol Regul Integr Comp Physiol (2002) 1.11

Reduction of serotonin transporters of patients with chronic fatigue syndrome. Neuroreport (2004) 1.11

Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun (2003) 1.10

Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons. J Biol Chem (2008) 1.10

Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: comparison between quantitative data obtained with microPET and ex vivo autoradiography. Neuroimage (2003) 1.09

Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro. Thromb Haemost (2004) 1.07

Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation. Hum Mol Genet (2006) 1.06

Relationship between cognitive functions and prevalence of fatigue in elementary and junior high school students. Brain Dev (2010) 1.06

Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. Gastroenterology (2005) 1.06

Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. Neuroimage (2002) 1.05

Unique expression patterns of 5-HT2A and 5-HT2C receptors in the rat brain during postnatal development: Western blot and immunohistochemical analyses. J Comp Neurol (2004) 1.05

Central nervous system fatigue alters autonomic nerve activity. Life Sci (2008) 1.04

Fatigue is a predictor for cardiovascular outcomes in patients undergoing hemodialysis. Clin J Am Soc Nephrol (2010) 1.03

Neural substrates of human facial expression of pleasant emotion induced by comic films: a PET Study. Neuroimage (2002) 1.02

Reliability and validity of the Japanese version of the Chalder Fatigue Scale among youth in Japan. Psychol Rep (2008) 1.01

Comparison of mice deficient in the high- or low-affinity neurotensin receptors, Ntsr1 or Ntsr2, reveals a novel function for Ntsr2 in thermal nociception. Brain Res (2004) 1.01

Establishment and assessment of a rat model of fatigue. Neurosci Lett (2003) 1.00

GTP hydrolysis by the Rho family GTPase TC10 promotes exocytic vesicle fusion. Dev Cell (2006) 1.00

G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity. J Neurosci (2008) 1.00

Nerve injury-activated microglia engulf myelinated axons in a P2Y12 signaling-dependent manner in the dorsal horn. Glia (2010) 0.99

MicroPET detection of enhanced 18F-FDG utilization by PKA inhibitor in awake rat brain. Brain Res (2005) 0.98

Mental fatigue caused by prolonged cognitive load associated with sympathetic hyperactivity. Behav Brain Funct (2011) 0.98

Reduced responsiveness is an essential feature of chronic fatigue syndrome: a fMRI study. BMC Neurol (2006) 0.97

Effects of chicken essence on recovery from mental fatigue in healthy males. Med Sci Monit (2013) 0.97

Medial orbitofrontal cortex is associated with fatigue sensation. Neurol Res Int (2010) 0.97

A submicrogram-scale protocol for biomolecule-based PET imaging by rapid 6pi-azaelectrocyclization: visualization of sialic acid dependent circulatory residence of glycoproteins. Angew Chem Int Ed Engl (2008) 0.96

Establishment of in vivo brain imaging method in conscious mice. J Nucl Med (2010) 0.96

Role of lactate in the brain energy metabolism: revealed by Bioradiography. Neurosci Res (2004) 0.96

Effects of Applephenon and ascorbic acid on physical fatigue. Nutrition (2007) 0.95

Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int J Mol Med (2003) 0.94

Autonomic nervous alterations associated with daily level of fatigue. Behav Brain Funct (2011) 0.93

Transgenic mouse overexpressing the Akt reduced the volume of infarct area after middle cerebral artery occlusion. Neurosci Lett (2004) 0.93

Imaging of aromatase distribution in rat and rhesus monkey brains with [11C]vorozole. Nucl Med Biol (2006) 0.93

Supraspinal regulation of physical fatigue. Neurosci Biobehav Rev (2011) 0.93

Pittsburgh compound B-negative dementia: a possibility of misdiagnosis of patients with non-alzheimer disease-type dementia as having AD. J Geriatr Psychiatry Neurol (2011) 0.93

Cognitive dysfunction and mental fatigue in childhood chronic fatigue syndrome--a 6-month follow-up study. Brain Dev (2011) 0.92

Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study. J Clin Psychopharmacol (2005) 0.92

Damage-induced neuronal endopeptidase is critical for presynaptic formation of neuromuscular junctions. J Neurosci (2010) 0.92

Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950. Appl Environ Microbiol (2013) 0.92

Changes in plasma and tissue amino acid levels in an animal model of complex fatigue. Nutrition (2009) 0.92

Daily oral administration of crocetin attenuates physical fatigue in human subjects. Nutr Res (2009) 0.91

A new hypothesis of chronic fatigue syndrome: co-conditioning theory. Med Hypotheses (2010) 0.91

Noxa is a critical mediator of p53-dependent motor neuron death after nerve injury in adult mouse. J Neurosci (2005) 0.91

Effects of mild-stream bathing on recovery from mental fatigue. Med Sci Monit (2010) 0.91

Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis. Gut (2006) 0.90

A chronic fatigue syndrome model demonstrates mechanical allodynia and muscular hyperalgesia via spinal microglial activation. Glia (2014) 0.90

Functional imaging of gustatory perception and imagery: "top-down" processing of gustatory signals. Neuroimage (2004) 0.90

The neural basis of academic achievement motivation. Neuroimage (2008) 0.90

Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats. Ann N Y Acad Sci (2004) 0.89

Vlgr1 is required for proper stereocilia maturation of cochlear hair cells. Genes Cells (2007) 0.89

The nuclear events guiding successful nerve regeneration. Front Mol Neurosci (2011) 0.89

Relationship between cognitive function and prevalence of decrease in intrinsic academic motivation in adolescents. Behav Brain Funct (2011) 0.89

Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system. Brain Res (2006) 0.89

A mechanism in Epstein-Barr virus oncogenesis: inhibition of transforming growth factor-beta 1-mediated induction of MAPK/p21 by LMP1. Virology (2002) 0.89

Unique anti-apoptotic activity of EAAC1 in injured motor neurons. EMBO J (2006) 0.89

Noninvasive imaging of dendrimer-type N-glycan clusters: in vivo dynamics dependence on oligosaccharide structure. Angew Chem Int Ed Engl (2010) 0.89